Dinaciclib
Dinaciclib is a novel and potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM in cell-free assays, respectively. It also blocks thymidine (dThd) DNA incorporation. Dinaciclib induces apoptosis through the activation of caspases 8 and 9. Phase 3.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | S2768 |
| Sku # | S2768-200mg |
| Pricing | 200mg, $1670.00 |
Citations for this product:
-
bioRxiv - Cancer Biology 2023Quote: ... Dinaciclib (SCH727965) was purchased from Selleck Chemicals (S2768). Dinaciclib was diluted in 20% hydroxypropyl-β-cyclodextrin (w/v ...